Neoplastic progression of breast epithelial cells - A molecular analysis

British Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 198-204

  Wei, W Z ^a   Pauley, R ^a   Lichlyter, D ^a   Soule, H ^a   Shi, W P ^a   Calaf, G ^b   Russo, J ^b   Jones, R F ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Differential display; MCF 10; Molecular marker; Neoplastic progression

Indexed keywords

BENZO[A]PYRENE; COMPLEMENTARY DNA; MESSENGER RNA;

ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER REGRESSION; CELL STRAIN MCF 7; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MASTECTOMY; MOLECULAR BIOLOGY; MOLECULAR CLONING; NORTHERN BLOTTING; ONCOGENE RAS; PLEURA EFFUSION; PRIORITY JOURNAL;

EID: 0031839538     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.464     Document Type: Article

References (20)

1. Bargmann CI, Hung MC and Weinberg RA (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226-230
2. Burchell J, Gendler S, Taylor-Papadiniitriou J, Girling A, Lewis A, Millis, R and Lamport D (1987) Development and characterization of breast cancer reactive monoclonal antibodies directed to the protein core of the human milk mucin. Cancer Res 47: 5476-5482
3. Calaf G and Russo J (1993) Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483-492
4. Calaf G, Zhang PL, Alvarado MV, Estrada S and Russo J (1995) c-Ha-ras enhances the neoplastic transformation of human breast epithelial cells treated with chemical carcinogens. Int J Oncol 6: 5-11
5. Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J and Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145: 61-89
6. Foulds L (1975) Neoplastic Development, Vols I and II. Academic Press: London
7. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C and Taylor-Papadimitriou J (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43: 1072-1076
8. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstam CM, Golouh R, Reed R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville AM, Burki K, Costiglione M, Collins J, Lindtner J and Senn HJ (1992) Prognostic importance of c-erb-2 expression in breast cancer. J Clin Oncol 10: 1049-1056
9. Jerome KR, Bu D and Finn OJ (1992) Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphoma transfected with epithelial mucin complementary DNA. Cancer Res 52: 5985-5990
10. Page DL and Dupont WD (1990) Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326-1335
11. Page DL, Dupont WD, Rogers LW and Rados MS (1985) Atypical hyperplastic lesions of the female breast - a long-term follow-up study. Cancer 55: 2648-2708
12. Paine TM, Soule HD, Pauley RJ and Dawson PJ (1992) Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int J Cancer 50: 463-473
13. Pauley RJ, Soule DH, Tait L, Miller FR, Wolman SR, Dawson PJ and Heppner GH (1993) The MCF-10 family of spontaneously immortalized human breast epithelial cell lines: models of neoplastic progression. Eur J Cancer Prev 2 (suppl. 3): 67-76
14. Pitol HC and Dragan YP (1991) Facts and theories concerning the mechanisms of carcinogenesis. FASEB J 5: 2280-2286
15. Sambrook J, Fritsch EF and Maniatis T (1989) In Molecular Cloning, a Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
16. Soule HD, Vazguez J, Long A, Albert S and Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416
17. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. MCF-10. Cancer Res 50: 6075-6086
18. Toikkanen S, Helin H, Isola J and Joensuu H (1992) Prognostic significance of Her-2 oncoprotein expression in breast cancer: a 30-year follow-up. J Clin Oncol 10: 1044-1048
19. Wright C, Nicholson S, Angus B, Sainbury JR, Farndon J, Cairns J, Harris AL and Horne CH (1992) Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer 65: 118-121
20. Xie Y, Pendergast AM and Hung MC (1995) Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/Neu. J Biol Chem 270: 30717-30724